Atorable 20 Tablet – Atorvastatin 20mg

Manufacturing & Quality Standards

Product Overview

Packaging Details

Target Trade Segment (B2B)
Why Include Atorable 20 in Your Cardiac Portfolio

Home/Products /atorvastatin-calcium-i-point-p-20mg-tablet

Atorable 20 Tablet

Composition : Atorvastatin Calcium I.P. 20mg Tablets

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹134/-

Manufacturing & Quality Standards

Atorable 20 Tablet is manufactured by Akums, one of India’s most trusted pharmaceutical manufacturers operating under WHO-GMP compliant facilities. The product follows standardized manufacturing protocols, batch-wise quality checks, and regulated documentation systems to ensure consistent quality and reliability for pharmaceutical trade distribution.

Product Overview

Atorable 20 Tablet is a branded cardiac care formulation from Cafoli Lifecare’s Cadray division, which is dedicated to cardiac, diabetic, and chronic care medicines. The product is developed for PCD pharma franchise distribution, wholesale supply, and institutional procurement channels across India.

The formulation is designed for long-term inclusion in chronic therapy portfolios managed by pharmaceutical distributors and franchise partners.

  • Consistent batch-to-batch formulation quality
  • Accurate dosage and composition labeling
  • Professional-grade Alu-Alu packaging
  • Compliance with Indian pharmaceutical regulations

Packaging Details

  • 10 x 10 tablets Alu-Alu blister packing
  • Uniform tablet presentation across batches
  • Secure outer carton with complete regulatory labeling
  • Packaging designed for safe logistics handling and inventory storage
Target Trade Segment (B2B)
  • Cardiac PCD Pharma Franchise Partners
  • Pharmaceutical Distributors & Stockists
  • Institutional & Bulk Medicine Suppliers
  • Hospital and Clinic Supply Chains

Atorable 20 Tablet is supplied strictly through pharmaceutical trade channels and is not positioned for direct-to-consumer sale.

Availability & Supply
  • Reliable stock availability for chronic care portfolios
  • Transparent dispatch timelines
  • GST-compliant invoicing with batch traceability
  • Trade-supportive MOQ options for franchise partners
Why Include Atorable 20 in Your Cardiac Portfolio
  • Manufactured by WHO-GMP certified Akums facilities
  • Stable formulation suitable for long-term cardiac therapy portfolios
  • Part of Cafoli Lifecare’s focused Cadray cardiac division
  • Designed for sustainable distributor and franchise growth
  • Backed by ethical marketing and compliance-driven practices

Read More

About the Product

Manufacturing & Quality Standards

Atorable 20 Tablet is manufactured by Akums, one of India’s most trusted pharmaceutical manufacturers operating under WHO-GMP compliant facilities. The product follows standardized manufacturing protocols, batch-wise quality checks, and regulated documentation systems to ensure consistent quality and reliability for pharmaceutical trade distribution.

Product Overview

Atorable 20 Tablet is a branded cardiac care formulation from Cafoli Lifecare’s Cadray division, which is dedicated to cardiac, diabetic, and chronic care medicines. The product is developed for PCD pharma franchise distribution, wholesale supply, and institutional procurement channels across India.

The formulation is designed for long-term inclusion in chronic therapy portfolios managed by pharmaceutical distributors and franchise partners.

  • Consistent batch-to-batch formulation quality
  • Accurate dosage and composition labeling
  • Professional-grade Alu-Alu packaging
  • Compliance with Indian pharmaceutical regulations

Packaging Details

  • 10 x 10 tablets Alu-Alu blister packing
  • Uniform tablet presentation across batches
  • Secure outer carton with complete regulatory labeling
  • Packaging designed for safe logistics handling and inventory storage
Target Trade Segment (B2B)
  • Cardiac PCD Pharma Franchise Partners
  • Pharmaceutical Distributors & Stockists
  • Institutional & Bulk Medicine Suppliers
  • Hospital and Clinic Supply Chains

Atorable 20 Tablet is supplied strictly through pharmaceutical trade channels and is not positioned for direct-to-consumer sale.

Availability & Supply
  • Reliable stock availability for chronic care portfolios
  • Transparent dispatch timelines
  • GST-compliant invoicing with batch traceability
  • Trade-supportive MOQ options for franchise partners
Why Include Atorable 20 in Your Cardiac Portfolio
  • Manufactured by WHO-GMP certified Akums facilities
  • Stable formulation suitable for long-term cardiac therapy portfolios
  • Part of Cafoli Lifecare’s focused Cadray cardiac division
  • Designed for sustainable distributor and franchise growth
  • Backed by ethical marketing and compliance-driven practices

Possible side effects include muscle pain, weakness, headache, and digestive discomfort. Rarely, serious side effects like muscle damage (rhabdomyolysis) or liver problems may occur. Contact your healthcare provider if you experience unexplained muscle pain, tenderness, or jaundice.

Used to treat high cholesterol, mixed lipid disorders, and to lower the risk of cardiovascular complications in patients with risk factors such as diabetes, hypertension, or existing heart disease.

Disclaimer: This product information is intended solely for pharmaceutical trade professionals, PCD pharma franchise partners, distributors, and institutional buyers. Atorable 20 Tablet is not promoted for direct consumer sale. All information is provided in compliance with applicable Indian pharmaceutical regulations.

Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation